Risk factors for medication non-adherence in an HIV infected population in the Dominican Republic

AIDS and Behavior

Volumn 15, Issue 7, 2011, Pages 1410-1415

  Harris, Julian ^a   Pillinger, Mara ^b   Fromstein, Deborah ^c   Gomez, Bayardo ^d   Garris, Peter A ^e   Kanetsky, Peter A ^f   Tebas, Pablo ^b,f   Gross, Robert ^b,f  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d Health Promotion and Human Solidarity Center (CEPROSH)   (Dominican Republic)

^e Galvan Health Center   (Dominican Republic)

^f UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adherence; Antiretroviral therapy; Developing world; HIV 1

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ADDICTION; ADULT; ARTICLE; CHILD; CROSS-SECTIONAL STUDY; DOMINICAN REPUBLIC; DRINKING BEHAVIOR; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATIENT COMPLIANCE; PRESCHOOL CHILD; RISK FACTOR; SOCIAL SUPPORT; STATISTICS;

ADULT; ALCOHOL DRINKING; ANTI-HIV AGENTS; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DOMINICAN REPUBLIC; FEMALE; HIV INFECTIONS; HUMANS; MEDICATION ADHERENCE; RISK FACTORS; SOCIAL SUPPORT; SUBSTANCE-RELATED DISORDERS;

EID: 84855162908     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-010-9781-1     Document Type: Article

References (34)

1. Gross R, Bilker WB, Friedman HM, Strom BL. Effect of adherence to newly initiated antiretroviral therapy on plasma viral load. AIDS. 2001;15:2109-17. (Pubitemid 33101818)
2. Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14:357-66. (Pubitemid 30182431)
3. Wood E, Hogg RS, Yip B, Harrigan PR, O'Shaughnessy MV, Montaner JS. Effect of medication adherence on survival of HIVinfected adults who start highly active antiretroviral therapy when the CD4 + cell count is 0.200 to 0.350 9 10(9) cells/L. Ann Internal Med. 2003;139:810-6.
4. Nachega JB, Hislop M, Dowdy DW, et al. Adherence to highly active antiretroviral therapy assessed by pharmacy claims predicts survival in HIV-infected South African adults. J Acquir Immune Defic Syndr. 2006;43:78-84. (Pubitemid 44306492)
5. Mills EJ, Nachega JB, Buchan I, et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North America: A meta-analysis. JAMA. 2006;296:679-90. (Pubitemid 44200639)
6. Bisson GP, Rowh A, Weinstein R, Gaolathe T, Frank I, Gross R. Antiretroviral failure despite high levels of adherence: Discordant adherence-response relationship in Botswana. J Acquir Immune Defic Syndr. 2008;49:107-10.
7. Starace F, Ammassari A, Trotta MP, et al. Depression is a risk factor for suboptimal adherence to highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31 Suppl 3:S136-9. (Pubitemid 35453574)
8. Arnsten JH, Demas PA, Grant RW, et al. Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med. 2002;17:377-81. (Pubitemid 34626108)
9. Holmes WC, Bilker WB, Wang H, Chapman J, Gross R. HIV/ AIDS-specific quality of life and adherence to antiretroviral therapy over time. J Acquir Immune Defic Syndr. 2007;46(3): 323-7. (Pubitemid 350287360)
10. Bouhnik AD, Chesney M, Carrieri P, et al. Nonadherence among HIV-infected injecting drug users: The impact of social instability. J Acquir Immune Defic Syndr. 2002;31 Suppl 3:S149-53. (Pubitemid 35453577)
11. Graham J, Bennett IM, Holmes WC, Gross R. Medication beliefs as mediators of the health literacy-antiretroviral adherence relationship in HIV-infected individuals. AIDS Behav. 2007;11: 385-92. (Pubitemid 46570813)
12. Tuller DM, Bangsberg DR, Senkungu J, Ware NC, Emenyonu N, Weiser SD. Transportation costs impede sustained adherence and access to HAART in a clinic population in Southwestern Uganda: A qualitative study. AIDS Behav 2009.
13. Harvey KM, Carrington D, Duncan J, et al. Evaluation of adherence to highly active antiretroviral therapy in adults in Jamaica. West Indian Med J. 2008;57:293-7.
14. Olupot-Olupot P, Katawera A, Cooper C, Small W, Anema A, Mills E. Adherence to antiretroviral therapy among a conflictaffected population in Northeastern Uganda: A qualitative study. AIDS. 2008;22:1882-4.
15. Millenium Development Goals. UNICEF. Available at: Http:// www.unicef.org/republicadominicana/english/overview-12559. htm. Accessed 30 October, 2009.
16. Encuesta Demografica y de Salud Republica Dominicana Informe Preliminar. Santo Domingo: Centro de Estudios Sociales y Demograficos; November 2007.
17. Cohen S, Kamarck T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385-96.
18. Giordano TP, Guzman D, Clark R, Charlebois ED, Bangsberg DR. Measuring adherence to antiretroviral therapy in a diverse population using a visual analogue scale. HIV Clin Trials. 2004; 5:74-9. (Pubitemid 38697081)
19. US Department of Agriculture. Alcoholic Beverages, Chap 9. Dietary Guidelines for Americans. Washington, D.C.: US Government Printing Office; 2005:43-46.
20. Pence BW, Thielman NM, Whetten K, Ostermann J, Kumar V, Mugavero MJ. Coping strategies and patterns of alcohol and drug use among HIV-infected patients in the United States Southeast. AIDS Patient Care STDS. 2008;22:869-77.
21. Hendershot CS, Stoner SA, Pantalone DW, Simoni JM. Alcohol use and antiretroviral adherence: Review and meta-analysis. J Acquir Immune Defic Syndr. 2009;52:180-202.
22. Samet JH, Horton NJ, Meli S, et al. A randomized controlled trial to enhance antiretroviral therapy adherence in patients with a history of alcohol problems. Antivir Ther. 2005;10:83-93. (Pubitemid 40767634)
23. Parsons JT, Golub SA, Rosof E, Holder C. Motivational interviewing and cognitive-behavioral intervention to improve HIV medication adherence among hazardous drinkers: A randomized controlled trial. J Acquir Immune Defic Syndr. 2007;46:443-50. (Pubitemid 350098695)
24. Merenstein D, Schneider MF, Cox C, et al. Association of child care burden and household composition with adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study. AIDS Patient Care STDS. 2009;23:289-96.
25. Carrieri MP, Leport C, Protopopescu C, et al. Factors associated with nonadherence to highly active antiretroviral therapy: A 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase. J Acquir Immune Defic Syndr. 2006;41:477-85.
26. Catz SL, Kelly JA, Bogart LM, Benotsch EG, McAuliffe TL. Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 2000;19:124-33.
27. Reynolds NR, Testa MA, Marc LG, et al. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: A multicenter, cross-sectional study. AIDS Behav. 2004;8:141-50. (Pubitemid 38888108)
28. Nachega JB, Knowlton AR, Deluca A, et al. Treatment supporter to improve adherence to antiretroviral therapy in HIV-infected South African adults. A qualitative study. J Acquir Immune Defic Syndr. 2006;43 Suppl 1:S127-33. (Pubitemid 44885652)
29. Koenig SP, Leandre F, Farmer PE. Scaling-up HIV treatment programmes in resource-limited settings: The rural Haiti experience. AIDS. 2004;18 Suppl 3:S21-5. (Pubitemid 39037455)
30. Behforouz HL, Farmer PE, Mukherjee JS. From directly observed therapy to accompagnateurs: Enhancing AIDS treatment outcomes in Haiti and in Boston. Clin Infect Dis. 2004;38 Suppl 5:S429-36. (Pubitemid 38738542)
31. Ware NC, Wyatt MA, Bangsberg DR. Examining theoretic models of adherence for validity in resource-limited settings. A heuristic approach. J Acquir Immune Defic Syndr. 2006;43 Suppl 1:S18-22. (Pubitemid 44885638)
32. Abaasa AM, Todd J, Ekoru K, et al. Good adherence to HAART and improved survival in a community HIV/AIDS treatment and care programme: The experience of The AIDS Support Organization (TASO), Kampala, Uganda. BMC Health Serv Res. 2008; 8:241.
33. Grossberg R, Zhang Y, Gross R. A time-to-prescription-refill measure of antiretroviral adherence predicted changes in viral load in HIV. J Clin Epidemiol. 2004;57:1107-10. (Pubitemid 39451804)
34. Gross R, Yip B, Re VL III, et al. A simple, dynamic measure of antiretroviral therapy adherence predicts failure to maintain HIV-1 suppression. J Infect Dis. 2006;194:1108-14. (Pubitemid 44547650)